文献速递乳房整形与再造

乳房扩张器置换为假体时预防性引流:必要还是多余

Prophylactic Drain Use in Breast Expander-to-Implant Exchange: Necessity or Nuisance?
PubMed 文献 · Plast Reconstr Surg · 2025-03-18

该回顾性研究分析2018至2023年乳房扩张器置换为假体的病例,比较放置引流与不放置引流的并发症率。未匹配比较中引流组总体并发症、假体暴露和取出率显著更高,尤其在胸肌前平面;但倾向评分匹配和多变量回归显示引流既不能预测也不预防并发症。作者认为引流不保护不良结局,但特定高解剖负担或合并症患者可能获益。

要点

  • 未匹配比较中引流组总体并发症12% vs 不引流组4.7%,假体暴露2.5% vs 0.3%,取出8.5% vs 2.6%,P<0.05。
  • 胸肌前平面引流组总体并发症11% vs 4.3%(P=0.014),暴露2.2% vs 0%(P=0.047),取出6.7% vs 2.2%(P=0.041)。
  • 倾向评分匹配、辅助手术分层和多变量回归显示引流既不能预测也不预防术后并发症。

核心结论

  • 引流在乳房假体再造第二阶段不保护不良结局,即使伴随辅助手术,且可能贡献更高并发症率,尤其在胸肌前平面。
  • 作者认为解剖负担重、包膜操作或切除广泛、或有合并症的患者可能从引流放置中获益。

研究设计与样本

  • 回顾性分析2018至2023年进行的乳房扩张器置换为假体手术,比较放置引流与不放置引流患者的并发症率。
  • 记录患者人口学、疾病、治疗和结局数据,使用倾向评分匹配减轻选择偏倚,多变量二元逻辑回归识别并发症显著预测因素。
  • 证据等级:治疗性,III级。

主要发现

  • 未匹配比较中,引流组总体并发症12% vs 不引流组4.7%,假体暴露2.5% vs 0.3%,假体取出8.5% vs 2.6%,P<0.05。
  • 胸肌前平面中,引流组总体并发症11% vs 不引流组4.3%(P=0.014),假体暴露2.2% vs 0%(P=0.047),假体取出6.7% vs 2.2%(P=0.041)。
  • 倾向评分匹配比较、伴随辅助手术分层和多变量逻辑回归显示,引流放置既不能预测也不预防术后并发症。

临床怎么用

  • 作者认为引流在乳房假体再造第二阶段不保护不良结局,即使伴随辅助手术,且可能贡献更高并发症率,尤其在胸肌前平面。
  • 作者认为解剖负担重、包膜操作或切除广泛、或有合并症的患者可能从引流放置中获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although drain placement is widely used during the tissue expander (TE) stage of implant-based breast reconstruction, it is unclear whether surgical drains are necessary at the TE-to-implant exchange stage. The authors sought to define clinical scenarios in which drains should and should not be used. METHODS: The authors retrospectively analyzed breast TE-to-implant exchanges performed from 2018 to 2023 and compared complication rates between patients treated with and without drains. Patient demographic, disease, treatment, and outcome data were recorded. Propensity score matching was used to mitigate selection bias. Multivariable binary logistic regression identified significant predictors of complications. RESULTS: In unmatched comparisons, rates of overall complications, implant exposure, and implant explantation were significantly higher in the drain group compared with the no-drain group (12% versus 4.7%, 2.5% versus 0.3%, and 8.5% versus 2.6%, respectively; P < 0.05). This was particularly evident in the prepectoral plane, where overall complication (11% versus 4.3%; P = 0.014), implant exposure (2.2% versus 0%; P = 0.047), and implant explantation (6.7% versus 2.2%; P = 0.041) rates were significantly higher with drains. However, propensity score-matched comparisons, stratification by concomitant ancillary procedures, and multivariable logistic regression showed that drain placement was neither predictive of nor protective against postoperative complications. CONCLUSIONS: Surgical drains do not protect against adverse outcomes in the second stage of implant-based breast reconstruction, even with ancillary procedures, and may contribute to higher complication rates, particularly in the prepectoral plane. However, patients with a heavy dissection burden, extensive capsular manipulation or resection, or comorbidities may benefit from drain placement. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Elmorsi R, Barrera JE, Chu C, et al. Prophylactic Drain Use in Breast Expander-to-Implant Exchange: Necessity or Nuisance? Plast Reconstr Surg. 2025. PMID: 40100210. doi:10.1097/PRS.0000000000012101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。